Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 + Oxaliplatin + Irinotecan in Advanced Gastric Cancer
NCT02527785Phase 2Completed
- Sponsor
- Hallym University Medical Center
- Start
- Feb 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in gastric cancer (GC), sponsored by Hallym University Medical Center. Started Feb 2015; status: completed.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02527785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527785.